SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Geron Corp. -- Ignore unavailable to you. Want to Upgrade?


To: wmwmw who wrote (780)1/16/1998 4:32:00 PM
From: OtherChap  Respond to of 3578
 
Stock might soar on Tuesday. There are only two factors
that will affect its price.

1) The 20/20 story could be positive or negative. Indications
are that it will be positive, especially if Hugh Downs is
doing the coverage.. 20/20 doesnt usually do slam pieces,
especially when he knows his audience is the older crowd.
If the coverage is neutral to positive, the stock should
rise quite a bit on the open tuesday- the story will attach
names and faces to this company, and make it more "real"
to people than it has been before..

2) Barrons could come out with a highly negative article over
the weekend, slamming the stock and telling everyone how
the company wont show any profits from this for years and
years, and how its the best short in history. IMO, this
is a very likely scenario. I expect it to be a cover story.

The question is, will a negative barron's article be cancelled
out by the positive 20/20 story?

We'll find out soon. I'm long with 10k shares at purchased
at 13, for the record.